Ana Navarro Discloses Using Mounjaro Injectable for Her Weight Loss
Ana Navarro told viewers during the Season 30 premiere of The View that she has been taking the injectable drug Mounjaro to help shed weight.
On the Season 30 debut of The View, co-host Ana Navarro revealed that she has been using the injectable drug Mounjaro to assist with weight loss, humorously noting a dramatic change in her on-stage look. Mounjaro, sold under the name Zepbound for obesity, works by activating both GLP-1 and GIP hormone receptors and is typically prescribed for type-2 diabetes. Navarro did not disclose specific figures regarding her weight loss or the start date of the treatment.
This admission comes after rumors three years earlier that she might have been on Ozempic, another GLP-1 medication, which she previously attributed to a wellness trip to Mexico. Other View panelists, including Joy Behar and Whoopi Goldberg, have also spoken publicly about using GLP-1 drugs to lose weight, highlighting a broader trend among celebrities to turn to these medications.
Why it matters
The story shows how high-profile personalities are openly discussing prescription weight-loss drugs, influencing public perception of these treatments.
In this story
